688131 皓元医药
2023/06 - 中期
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
2019/12
人民币(K¥)
经营活动产生之现金流量净额(195,013)(240,233)57,835116,78957,071
投资活动产生之现金流量净额(240,644)(713,002)(305,839)(74,161)(70,475)
筹资活动产生之现金流量净额238,474360,3241,007,29450,277131,160
汇率变动对现金及现金等价物的影响8,72214,415(7,242)(9,290)1,347
现金及现金等价物净增加/(减少)(188,461)(578,496)752,04783,616119,104
期初现金及现金等价物余额455,2641,033,760281,713198,09778,994
期末现金及现金等价物余额266,803455,2641,033,760281,713198,097